fbpx

See If You Qualify For The Migraine Research trial

The purpose of this clinical research study is to test if Fremanezumab is effective in Preventing Chronic Migraine in patients 6 to 17 years of age.

Qualified participants will receive:

  •  Study-related migraine treatment at no cost
  •  Study-related medical exams at no cost
  •  Compensation up to $250 for time and travel
3 EASY STEPS

How It Works

Step 1

Step 1

Fill out the form to instantly see if you qualify. You can also give us a call at 561-689-0606.
Step 2

Step 2

A member of our team will reach out shortly and may ask some additional questions. 
Step 3

Step 3

If you’re qualified, you will have the opportunity to schedule an office visit for an exam. 
Vaccine for anyone over age 60

Vaccine for anyone over age 60

The purpose of this research study is to demonstrate the efficacy of a single dose of GSK’s RSVPreF3 OA investigational vaccine in adults aged 60 years and above.

RSV (Common Cold)

RSV (Common Cold)

This research study is to evaluate the effectiveness and safety of an oral investigational medication for the treatment of Acute Upper Respiratory Infection.

MIGRAINE ?

MIGRAINE ?

This research study is to demonstrate the efficacy, safety, and tolerability of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of Migraines.

Subscribe to our newsletter

Get notified by email about our current and upcoming clinical studies. Receive articles of clinical news and blog updates. 

Subscribe Now


Scroll to Top